Andrew Engdahl, the Head of Sales at the post-click automation leader Instapage, has been officially nominated as a candidate for the Blood Cancer United Visionaries of the Year campaign. This prestigious nomination recognizes influential community leaders who leverage their professional platforms and personal networks to generate significant funding and awareness for the fight against blood cancers, including leukemia, lymphoma, and myeloma. Engdahl’s candidacy is not merely a philanthropic endeavor but a deeply personal mission rooted in his own survival of a life-threatening Stage 4 Non-Hodgkin’s Lymphoma diagnosis. As he leads the global sales initiatives for Instapage, Engdahl is now channeling his professional acumen into a high-stakes fundraising campaign with a target of $50,000, aimed at supporting research and providing resources for patients currently navigating the complexities of a cancer diagnosis.
The Visionaries of the Year campaign is a competitive, time-sensitive philanthropic challenge that brings together leaders across various industries. Candidates are selected based on their leadership skills, community involvement, and their ability to inspire others to contribute to a cause that affects millions of families globally. For Engdahl, the nomination serves as a milestone in a journey that began with a sudden health crisis and culminated in a renewed commitment to advocacy and "paying it forward."
The Chronology of a Crisis: From Diagnosis to Remission
The trajectory of Andrew Engdahl’s life changed abruptly in the summer of 2022. At the time, Engdahl was a high-performing executive, managing complex sales cycles and driving growth for Instapage. What initially appeared to be routine physical discomfort—misinterpreted as simple muscle tension—rapidly escalated into a medical emergency. Following a series of diagnostic tests, Engdahl was informed that he was suffering from Stage 4 Non-Hodgkin’s Lymphoma, an aggressive form of blood cancer that had already begun to impact his skeletal integrity.
The diagnosis necessitated immediate and intensive medical intervention. The timeline of his treatment was grueling: Engdahl underwent major spinal surgery to address the damage caused by the malignancy, followed by a rigorous regimen of six chemotherapy infusions. To ensure the cancer had not breached the central nervous system, he endured four lumbar punctures, a procedure involving the insertion of a needle into the spinal canal to collect cerebrospinal fluid or deliver medication.
The recovery process extended beyond the hospital walls. Engdahl committed to six months of intensive physical therapy and yoga to regain his mobility and strength. This holistic approach to recovery allowed him to return to his leadership role at Instapage with a new perspective on resilience. Now approaching three years in remission, Engdahl’s transition from a patient fighting for survival to a "Visionary" fundraising for the future represents a full-circle evolution of his personal and professional identity.
Understanding Non-Hodgkin’s Lymphoma: Data and Context
To understand the weight of Engdahl’s survival and the importance of his campaign, one must look at the broader landscape of blood cancers. Non-Hodgkin’s Lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system. According to data from the American Cancer Society, NHL is one of the most common cancers in the United States, accounting for about 4% of all cancer diagnoses.
In 2024 alone, it is estimated that over 80,000 people will be diagnosed with NHL. While advancements in treatment have significantly improved the five-year survival rate—which currently stands at approximately 74%—the prognosis varies heavily based on the subtype and the stage at which the cancer is detected. A Stage 4 diagnosis, such as the one Engdahl faced, indicates that the cancer has spread to at least one organ outside the lymphatic system, such as the bone marrow, liver, or lungs.
The research funded by organizations like Blood Cancer United is critical because it focuses on targeted therapies and immunotherapies that have higher success rates and fewer long-term side effects than traditional chemotherapy. The $50,000 goal set by Engdahl’s campaign is designed to contribute directly to these scientific breakthroughs, ensuring that future patients have access to the same life-saving innovations that aided his recovery.
The Visionaries of the Year Campaign: Structure and Impact
The Visionaries of the Year program is a 10-week philanthropic competition. Candidates like Engdahl are tasked with building "campaign teams" to reach their fundraising goals. The title of "Visionary of the Year" is awarded to the candidate who raises the most funds in their local community, but the broader impact lies in the collective total raised by all participants.
Engdahl officially launched his campaign on World Cancer Day, a global initiative led by the Union for International Cancer Control (UICC). By aligning his campaign launch with this international day of awareness, Engdahl sought to maximize the reach of his message. His campaign focuses on three primary pillars:
- Research: Funding the next generation of blood cancer treatments.
- Patient Support: Providing financial assistance and educational resources to families currently in the "thick of the fight."
- Advocacy: Using his voice to influence policy changes that improve access to care for cancer patients.
In a statement regarding his motivation, Engdahl emphasized the concept of debt to the medical and support communities: "I feel that I owe it to my physicians, my friends, family, and teammates, and all those affected by the scourge of blood cancer to pay it forward and make a difference while I still have the strength and ability to do so."
Corporate Leadership and Philanthropic Responsibility
The support Engdahl has received from Instapage highlights a growing trend in the corporate world: the integration of executive personal journeys into company culture and social responsibility initiatives. As Head of Sales, Engdahl is responsible for the revenue engine of a major tech firm. His ability to close the company’s largest deals while navigating a Stage 4 diagnosis has become a testament to his professional tenacity.
Instapage has taken an active role in amplifying Engdahl’s campaign, utilizing its platform to reach partners, clients, and employees. This corporate backing is indicative of a shift toward "authentic leadership," where executives are encouraged to be transparent about their challenges. By sharing Engdahl’s story, Instapage not only supports a colleague but also fosters a workplace culture centered on empathy and resilience.
From a strategic standpoint, such initiatives can also strengthen brand reputation. Consumers and B2B clients are increasingly looking to partner with companies that demonstrate a commitment to social causes. Instapage’s public endorsement of Engdahl’s campaign serves as a signal to the market that the company values its people and is invested in the health of the broader community.
Broader Implications and Analysis
The success of individual-led campaigns like Engdahl’s has significant implications for the non-profit sector. Traditional fundraising often relies on large-scale galas or corporate grants; however, the "Visionaries" model leverages the "peer-to-peer" fundraising power of high-profile individuals. This decentralized approach allows non-profits to tap into networks that might otherwise be inaccessible, such as the specialized tech and SaaS (Software as a Service) communities in which Engdahl operates.
Furthermore, Engdahl’s focus on the "joy and optimism" he brings to the sales floor suggests a psychological shift in how cancer survival is discussed in professional settings. Rather than being viewed through a lens of deficit, his experience is framed as a source of "resilience," a trait highly prized in the volatile tech industry.
The data suggests that the funding raised through these campaigns is more necessary than ever. While the survival rates for certain blood cancers have doubled or even tripled since the 1960s, blood cancers still claim the lives of more than 150 people every day in the United States. The financial burden of treatment also remains a significant hurdle; the cost of specialized cancer drugs can exceed $100,000 per year, making patient support programs a vital lifeline for many.
Conclusion and Future Outlook
As Andrew Engdahl’s campaign progresses toward its $50,000 goal, the focus remains on the tangible benefits these funds will provide. For the patients currently undergoing the same lumbar punctures and chemotherapy infusions that Engdahl once did, the campaign represents hope and the promise of better outcomes. For the scientific community, it represents the fuel needed to continue the pursuit of a cure.
Engdahl’s journey from a life-threatening diagnosis in 2022 to his current role as a global sales leader and philanthropic visionary serves as a powerful narrative of recovery. His efforts, backed by the team at Instapage and the wider Blood Cancer United community, underscore the importance of using one’s platform for the greater good. As the 10-week campaign continues, the tech and philanthropic communities will be watching closely, seeing how one leader’s second chance at life can help secure a first chance for many others.
